Clinical Significance of Serum Zinc Levels on the Development of Sarcopenia in Cirrhotic Patients.
Cancer Diagn Progn
; 2(2): 184-193, 2022.
Article
em En
| MEDLINE
| ID: mdl-35399181
ABSTRACT
Background/Aim:
Sarcopenia increases the mortality in patients with cirrhosis. Approximately 60% of zinc is accumulated in skeletal muscle. We aimed to determine the role of subclinical zinc deficiency on sarcopenia development in patients with cirrhosis. Patients andMethods:
We enrolled 151 patients with cirrhosis and divided them into the group with normal serum zinc levels (Group N 80-130 µg/dl; n=38) and group with subclinical zinc deficiency (Group D <80 µg/dl; n=113). The risk factors for sarcopenia were then investigated.Results:
Group D had more sarcopenia cases than Group N (31.0% vs. 13.2%). In group D, HGS exhibited a weakly positive but significant correlation with serum zinc levels (R=0.287, p=0.00212), serum zinc levels negatively correlated with both ammonia and myostatin levels (R=-0.254, p=0.0078; R=-0.33, p<0.01), and low zinc levels were independently associated with sarcopenia development.Conclusion:
Patients with cirrhosis showing subclinical zinc deficiency have a significantly higher risk of developing sarcopenia.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Risk_factors_studies
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article